5 Best Biotech Penny Stocks To Buy Now

Page 5 of 5

1. Tricida, Inc. (NASDAQ:TCDA)

Number of Hedge Fund Holders: 22

Share Price as of November 29: $0.26

Tricida, Inc. (NASDAQ:TCDA) develops and commercializes veverimer, a non-absorbed orally-administered polymer to treat metabolic acidosis in patients with chronic kidney disease. The company is based in South San Francisco, California.

On October 25, Serge Belanger at Needham placed a Hold rating on Tricida, Inc. (NASDAQ:TCDA).

Tricida, Inc. (NASDAQ:TCDA) reported an EPS of -$0.44 in the third quarter, beating estimates by $0.10. The company’s cash, cash equivalents and investments were $80.2 million as of this September.

In total, 22 hedge funds were long Tricida, Inc. (NASDAQ:TCDA) in the third quarter. Their total stake value was $216.2 million.

Follow Tricida Inc.

See also Biggest Korean Companies by Market Cap and Largest Retailers in the US.

Page 5 of 5